CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME
Clinical trials for CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME trials appear
Sign up with your email to follow new studies for CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could adding a second diabetes drug early save lives?
Knowledge-focused CompletedThis study analyzed health records of over 118,000 adults with obesity, type 2 diabetes, and related heart, kidney, and liver conditions. Researchers compared people who added a second type of diabetes drug (GLP-1 or SGLT2) early to those who did not. The goal was to see if early…
Matched conditions: CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Could adding a second diabetes drug early save lives?
Knowledge-focused CompletedThis study analyzed health records from over 450,000 adults with obesity and type 2 diabetes to see if adding a GLP-1 or SGLT2 drug early improves survival and kidney health. Researchers compared those who added the other drug class within 90 days to those who added a different d…
Matched conditions: CARDIOVASCULAR-KIDNEY-METABOLIC SYNDROME
Sponsor: Chung Shan Medical University • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC